• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXAL085902B
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Obstruction/Occlusion (2422)
Event Date 08/25/2021
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following information was reported to gore: on (b)(6) 2021 a patient was undergoing treatment of bilateral iliac artery aneurysm with gore® excluder® aaa endoprostheses and gore® excluder® iliac branch endoprostheses.Following deployment of the (b)(4) on the right, attempts were made to access the internal iliac artery with a wire, however the wire kept landing subintimally, so the right side was left untreated.Attempts were made to treat the left side with the gore® excluder® iliac branch endoprostheses, but the internal iliac artery was too short.A decision was made to use a gore® viabahn® vbx balloon expandable endoprosthesis.Following implantation of the viabahn® vbx balloon expandable endoprosthesis, blood flow was sluggish and by the end of the procedure this device was occluded, either due to poor outflow or a distal dissection possibly from the shoulders of the viabahn® vbx balloon expandable endoprosthesis balloon.Some time following the procedure, the patient developed spinal cord ischemia due to lack of perfusion to the inferior mesenteric and iliac arteries.An unexplained stroke was also recognized.This report addresses the occlusion of the gore® viabahn® vbx balloon expandable endoprosthesis.
 
Manufacturer Narrative
H.6.Results code 1: 3233 a review of the manufacturing, sterilization and heparin coatings records verified the lot met all pre-release manufacturing and sterilization specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
heidi inskeep
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12422160
MDR Text Key276651549
Report Number2017233-2021-02331
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeCA
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/02/2023
Device Catalogue NumberBXAL085902B
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/25/2021
Initial Date FDA Received09/03/2021
Supplement Dates Manufacturer Received11/15/2021
Supplement Dates FDA Received11/15/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-